double blind

A testing procedure designed to avoid biased results by ensuring that at the time of the test neither the administrators nor the subjects know which subjects are receiving a test treatment and which belong to a control group.

dou′ble-blind′ adj.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

ThesaurusAntonymsRelated WordsSynonymsLegend:

Noun

double blind - a test procedure in which the identity of those receiving the intervention is concealed from both the administrators and the subjects until after the test is completed; designed to reduce or eliminate bias in the results

trial, run, test - the act of testing something; "in the experimental trials the amount of carbon was measured separately"; "he called each flip of the coin a new trial"

Mentioned in

References in periodicals archive

In a randomized, double blind, placebo-controlled clinical trial conducted in the U.

NurOwn Phase 2 ALS Trial Abstracts Set For Platform Presentations

M2 EQUITYBITES-December 30, 2015-Camurus and Braeburn Pharmaceuticals report enrollment of first patient in double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients

Camurus and Braeburn Pharmaceuticals report enrollment of first patient in double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients

M2 PHARMA-December 30, 2015-Camurus and Braeburn Pharmaceuticals report enrollment of first patient in double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients

Camurus and Braeburn Pharmaceuticals report enrollment of first patient in double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients

A 22-week, multicenter, randomized, double blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.

Evidence based medicine and medical biotechnology

The study included 611 outpatients with clinically stable schizophrenia who were randomized double blind 2:1 to 12 months of flexibly dosed oral lurasidone (Latuda) at 37-111 mg/day or to oral risperidone (Risperdal) at 2-6 mg/day.

Lurasidone favorably affects metabolic syndrome

He told me that only double blind studies were of value.

Sound off! Are you a double blind doctor?

This experiment today would not be acceptable because it was not double blind, was not randomized, was too simple, did not cost enough, and had too few subjects in the study.

The emperor has no clothes: an anecdote